🇺🇸 FDA
Pipeline program

SC262

SC262-101

Phase 1 small_molecule active

Quick answer

SC262 for Non Hodgkin's Lymphoma is a Phase 1 program (small_molecule) at Sana Biotechnology with 1 ClinicalTrials.gov record(s).

Program details

Company
Sana Biotechnology
Indication
Non Hodgkin's Lymphoma
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials